MeiraGTx Holdings plc Deferred Income Tax Liabilities, Net
MeiraGTx Holdings plc (MGTX) had Deferred Income Tax Liabilities, Net of $184.00 thousand as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2024-03-15
- 2023-09-30: Deferred Income Tax Liabilities, Net $184.00K.
- 2023-06-30: Deferred Income Tax Liabilities, Net $189.00K.
- 2023-03-31: Deferred Income Tax Liabilities, Net $189.00K.
- 2022-12-31: Deferred Income Tax Liabilities, Net $186.00K.
| Period end | Deferred Income Tax Liabilities, Net | Deferred Income Tax Liabilities, Net as first filed |
|---|---|---|
| 2023-09-30 | $184.00K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $189.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $189.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $186.00K 10-K · filed 2024-03-15 | |
| 2022-09-30 | $171.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $181.00K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $194.00K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $196.00K 10-K · filed 2023-03-14 | |
| 2021-09-30 | $201.00K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $206.00K 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $204.00K 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $214.00K 10-K · filed 2022-03-10 | $213.72K 10-K · filed 2021-03-11 |
| 2020-09-30 | $203.25K 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $194.32K 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $191.20K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $195.05K 10-K · filed 2021-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |